284 related articles for article (PubMed ID: 15951190)
1. The metabolism of glycosaminoglycans is impaired in prion diseases.
Mayer-Sonnenfeld T; Zeigler M; Halimi M; Dayan Y; Herzog C; Lasmezas CI; Gabizon R
Neurobiol Dis; 2005 Dec; 20(3):738-43. PubMed ID: 15951190
[TBL] [Abstract][Full Text] [Related]
2. Tissue plasminogen activator in brain tissues infected with transmissible spongiform encephalopathies.
Xanthopoulos K; Paspaltsis I; Apostolidou V; Petrakis S; Siao CJ; Kalpatsanidis A; Grigoriadis N; Tsaftaris A; Tsirka SE; Sklaviadis T
Neurobiol Dis; 2005 Nov; 20(2):519-27. PubMed ID: 15922607
[TBL] [Abstract][Full Text] [Related]
3. Prion proteins: a biological role beyond prion diseases.
Hu W; Rosenberg RN; Stüve O
Acta Neurol Scand; 2007 Aug; 116(2):75-82. PubMed ID: 17661791
[TBL] [Abstract][Full Text] [Related]
4. Methionine sulfoxides on PrPSc: a prion-specific covalent signature.
Canello T; Engelstein R; Moshel O; Xanthopoulos K; Juanes ME; Langeveld J; Sklaviadis T; Gasset M; Gabizon R
Biochemistry; 2008 Aug; 47(34):8866-73. PubMed ID: 18680312
[TBL] [Abstract][Full Text] [Related]
5. Differential solubility of prions is associated in manifold phenotypes.
Kuczius T; Karch H; Groschup MH
Mol Cell Neurosci; 2009 Nov; 42(3):226-33. PubMed ID: 19607920
[TBL] [Abstract][Full Text] [Related]
6. The neuropathological phenotype in transgenic mice expressing different prion protein constructs.
DeArmond SJ; Yang SL; Cayetano-Canlas J; Groth D; Prusiner SB
Philos Trans R Soc Lond B Biol Sci; 1994 Mar; 343(1306):415-23. PubMed ID: 7913760
[TBL] [Abstract][Full Text] [Related]
7. Mouse-adapted sporadic human Creutzfeldt-Jakob disease prions propagate in cell culture.
Lawson VA; Vella LJ; Stewart JD; Sharples RA; Klemm H; Machalek DM; Masters CL; Cappai R; Collins SJ; Hill AF
Int J Biochem Cell Biol; 2008; 40(12):2793-801. PubMed ID: 18590830
[TBL] [Abstract][Full Text] [Related]
8. Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice.
Pfeifer A; Eigenbrod S; Al-Khadra S; Hofmann A; Mitteregger G; Moser M; Bertsch U; Kretzschmar H
J Clin Invest; 2006 Dec; 116(12):3204-10. PubMed ID: 17143329
[TBL] [Abstract][Full Text] [Related]
9. Human prion diseases: molecular and clinical aspects.
Glatzel M; Stoeck K; Seeger H; Lührs T; Aguzzi A
Arch Neurol; 2005 Apr; 62(4):545-52. PubMed ID: 15824251
[TBL] [Abstract][Full Text] [Related]
10. Truncated PrP(c) in mammalian brain: interspecies variation and location in membrane rafts.
Laffont-Proust I; Hässig R; Haïk S; Simon S; Grassi J; Fonta C; Faucheux BA; Moya KL
Biol Chem; 2006 Mar; 387(3):297-300. PubMed ID: 16542151
[TBL] [Abstract][Full Text] [Related]
11. Altered prion protein glycosylation in the aging mouse brain.
Goh AX; Li C; Sy MS; Wong BS
J Neurochem; 2007 Feb; 100(3):841-54. PubMed ID: 17144900
[TBL] [Abstract][Full Text] [Related]
12. Involvement of glypican-1 autoprocessing in scrapie infection.
Löfgren K; Cheng F; Fransson LA; Bedecs K; Mani K
Eur J Neurosci; 2008 Sep; 28(5):964-72. PubMed ID: 18717736
[TBL] [Abstract][Full Text] [Related]
13. Reduction of protein kinase MARK4 in the brains of experimental scrapie rodents and human prion disease correlates with deposits of PrP(Sc).
Gong HS; Guo Y; Tian C; Xie WL; Shi Q; Zhang J; Xu Y; Wang SB; Zhang BY; Chen C; Liu Y; Dong XP
Int J Mol Med; 2012 Sep; 30(3):569-78. PubMed ID: 22692785
[TBL] [Abstract][Full Text] [Related]
14. Cellular prion protein co-localizes with nAChR beta4 subunit in brain and gastrointestinal tract.
Petrakis S; Irinopoulou T; Panagiotidis CH; Engelstein R; Lindstrom J; Orr-Urtreger A; Gabizon R; Grigoriadis N; Sklaviadis T
Eur J Neurosci; 2008 Feb; 27(3):612-20. PubMed ID: 18279314
[TBL] [Abstract][Full Text] [Related]
15. [Mechanisms of prion transmission].
Sakaguchi S
Nihon Rinsho; 2007 Aug; 65(8):1391-5. PubMed ID: 17695274
[TBL] [Abstract][Full Text] [Related]
16. Chemically induced accumulation of GAGs delays PrP(Sc) clearance but prolongs prion disease incubation time.
Mayer-Sonnenfeld T; Avrahami D; Friedman-Levi Y; Gabizon R
Cell Mol Neurobiol; 2008 Nov; 28(7):1005-15. PubMed ID: 18350378
[TBL] [Abstract][Full Text] [Related]
17. Utility of RNAi-mediated prnp gene silencing in neuroblastoma cells permanently infected by prions: potentials and limitations.
Kim Y; Han B; Titlow W; Mays CE; Kwon M; Ryou C
Antiviral Res; 2009 Nov; 84(2):185-93. PubMed ID: 19748523
[TBL] [Abstract][Full Text] [Related]
18. The scrapie prion protein is present in flotillin-1-positive vesicles in central- but not peripheral-derived neuronal cell lines.
Pimpinelli F; Lehmann S; Maridonneau-Parini I
Eur J Neurosci; 2005 Apr; 21(8):2063-72. PubMed ID: 15869502
[TBL] [Abstract][Full Text] [Related]
19. Prion protein is ubiquitinated after developing protease resistance in the brains of scrapie-infected mice.
Kang SC; Brown DR; Whiteman M; Li R; Pan T; Perry G; Wisniewski T; Sy MS; Wong BS
J Pathol; 2004 May; 203(1):603-8. PubMed ID: 15095484
[TBL] [Abstract][Full Text] [Related]
20. The role of rafts in the fibrillization and aggregation of prions.
Pinheiro TJ
Chem Phys Lipids; 2006 Jun; 141(1-2):66-71. PubMed ID: 16647049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]